BioLineRx Ltd. (BLRX.TA)
ILA 5.8
(-9.38%)
ILA 5.8
(-9.38%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 63.92 Million USD | -16.31% |
| 2022 | 76.38 Million USD | -6.15% |
| 2021 | 81.39 Million USD | 72.11% |
| 2020 | 47.29 Million USD | -11.72% |
| 2019 | 53.56 Million USD | -4.74% |
| 2018 | 56.23 Million USD | -7.76% |
| 2017 | 60.96 Million USD | 56.57% |
| 2016 | 38.93 Million USD | -24.1% |
| 2015 | 51.3 Million USD | 41.85% |
| 2014 | 36.16 Million USD | 81.3% |
| 2013 | 19.94 Million USD | -17.93% |
| 2012 | 24.3 Million USD | -17.15% |
| 2011 | 29.33 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 51.6 Million USD | -19.28% |
| 2024 Q2 | 64.59 Million USD | 25.19% |
| 2023 FY | 63.92 Million USD | -16.31% |
| 2023 Q2 | 58.93 Million USD | -14.15% |
| 2023 Q1 | 68.64 Million USD | -10.13% |
| 2023 Q3 | 52.85 Million USD | -10.32% |
| 2023 Q4 | 63.92 Million USD | 20.94% |
| 2022 Q1 | 74.77 Million USD | -8.13% |
| 2022 FY | 76.38 Million USD | -6.15% |
| 2022 Q4 | 76.38 Million USD | -6.48% |
| 2022 Q3 | 81.67 Million USD | 20.39% |
| 2022 Q2 | 67.83 Million USD | -9.27% |
| 2021 Q2 | 91.32 Million USD | 9.25% |
| 2021 Q1 | 83.59 Million USD | 76.78% |
| 2021 FY | 81.39 Million USD | 72.11% |
| 2021 Q4 | 81.39 Million USD | -6.34% |
| 2021 Q3 | 86.9 Million USD | -4.84% |
| 2020 Q3 | 46.03 Million USD | -13.12% |
| 2020 FY | 47.29 Million USD | -11.72% |
| 2020 Q1 | 47.17 Million USD | -11.94% |
| 2020 Q4 | 47.29 Million USD | 2.72% |
| 2020 Q2 | 52.98 Million USD | 12.33% |
| 2019 Q3 | 57.22 Million USD | -7.64% |
| 2019 Q2 | 61.95 Million USD | -8.34% |
| 2019 Q1 | 67.59 Million USD | 20.2% |
| 2019 FY | 53.56 Million USD | -4.74% |
| 2019 Q4 | 53.56 Million USD | -6.39% |
| 2018 Q3 | 46.4 Million USD | -11.13% |
| 2018 Q2 | 52.21 Million USD | -6.89% |
| 2018 Q1 | 56.07 Million USD | -8.02% |
| 2018 Q4 | 56.23 Million USD | 21.19% |
| 2018 FY | 56.23 Million USD | -7.76% |
| 2017 Q2 | 63.04 Million USD | 53.33% |
| 2017 Q4 | 60.96 Million USD | -7.81% |
| 2017 Q3 | 66.12 Million USD | 4.88% |
| 2017 Q1 | 41.11 Million USD | 5.6% |
| 2017 FY | 60.96 Million USD | 56.57% |
| 2016 Q2 | 45.68 Million USD | -6.66% |
| 2016 Q3 | 42.27 Million USD | -7.45% |
| 2016 Q4 | 38.93 Million USD | -7.9% |
| 2016 Q1 | 48.94 Million USD | -4.6% |
| 2016 FY | 38.93 Million USD | -24.1% |
| 2015 Q3 | 55.03 Million USD | -5.7% |
| 2015 Q4 | 51.3 Million USD | -6.78% |
| 2015 FY | 51.3 Million USD | 41.85% |
| 2015 Q2 | 58.35 Million USD | -2.54% |
| 2015 Q1 | 59.87 Million USD | 65.55% |
| 2014 Q2 | 35.03 Million USD | -10.11% |
| 2014 Q1 | 38.97 Million USD | 95.39% |
| 2014 FY | 36.16 Million USD | 81.3% |
| 2014 Q4 | 36.16 Million USD | 16.82% |
| 2014 Q3 | 30.95 Million USD | -11.64% |
| 2013 Q1 | 30.65 Million USD | 26.13% |
| 2013 FY | 19.94 Million USD | -17.93% |
| 2013 Q4 | 19.94 Million USD | -9.91% |
| 2013 Q3 | 22.14 Million USD | -11.28% |
| 2013 Q2 | 24.95 Million USD | -18.6% |
| 2012 Q3 | 28.16 Million USD | -15.53% |
| 2012 FY | 24.3 Million USD | -17.15% |
| 2012 Q1 | 39.31 Million USD | 34.0% |
| 2012 Q2 | 33.34 Million USD | -15.19% |
| 2012 Q4 | 24.3 Million USD | -13.7% |
| 2011 Q3 | 33.04 Million USD | -12.38% |
| 2011 Q4 | 29.33 Million USD | -11.21% |
| 2011 FY | 29.33 Million USD | 0.0% |
| 2011 Q1 | 41.02 Million USD | 0.0% |
| 2011 Q2 | 37.71 Million USD | -8.07% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Matricelf Ltd | 39.49 Million ILA | -61.86% |